<qa>  How many randomized subjects are planned for this trial?Approximately 632 randomized subjects are planned for this trial. In this study, one-half of the subjects 316 subjects will receive Neutrolin as a study drug and the other half will receive heparin 4,000 USP Units4mL 1,000 USP UnitsmL with benzyl alcohol preservative as a comparator. Subjects will be assigned in a 1:1 ratio using permuted blocks without additional stratification for both groups. 